Search filters

List of works by Anna Felisiak-Golabek

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas

scientific article published on 4 November 2016

Cytoplasmic HAX1 Is an Independent Risk Factor for Breast Cancer Metastasis

scientific article published on 10 April 2019

Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach

scientific article

Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases.

scientific article

Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases

scientific article published on 22 July 2016

GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases

scientific article published on 10 March 2017

Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression

scientific article published on 7 October 2017

Intranodal palisaded myofibroblastoma: another mesenchymal neoplasm with CTNNB1 (β-catenin gene) mutations: clinicopathologic, immunohistochemical, and molecular genetic study of 18 cases

scientific article

New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs

scientific article published on 2 August 2017

New fusion sarcomas: histopathology and clinical significance of selected entities

scientific article published on 08 January 2019

Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.

scientific article published on 28 November 2014

Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors

scientific article published on 13 February 2019

SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.

scientific article published on 28 February 2017

Paulina is supported by:

About Paulina

Help